Nucleic Acid Therapeutics is the leading journal in its field focusing on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. The Journal examines many new approaches for using nucleic acids as therapeutic agents or in modifying nucleic acids for therapeutic purposes including: oligonucleotides, gene modification, aptamers, RNA nanoparticles, and ribozymes.  
Nucleic Acid Therapeutics coverage includes:
RNAi: siRNAs, shRNAs, and miRNAs
Antisense applications; nucleoside and nucleotide analogs and modifications
Peptide nucleic acids
DNA-modified gene therapy
Nucleic acid-based nanoparticles
Ethical, legal, and regulatory issues
Nucleic Acid Therapeutics is under the editorial leadership of Co-Editors-in-Chief Bruce A. Sullenger, PhD, Duke Translational Research Institute, Duke University Medical Center and Annemieke Aartsma-Rus, PhD, Leiden University Medical Center; Executive Editor Graham C. Parker, PhD; and other leading investigators. 
Audience: Molecular biologists, biochemists, DNA and cell biologists, and biopharmaceutical researchers, among others.  

Co-Editors-in-Chief
Bruce A. Sullenger, PhD
Director, Duke Translational Research Institute
Joseph and Dorothy Beard Professor
Department of Surgery 
Duke University Medical Center
Durham, NC   
bruce.sullenger@duke.edu
Annemieke Aartsma-Rus, PhD    
Professor of Translational Genetics
Department of Human Genetics    
Leiden University Medical Center        
Leiden, Netherlands        
A.M.Aartsma-Rus@lumc.nl
Executive Editor
Graham C. Parker, PhD
gparker@liebertpub.com
Senior Editors
David Corey, PhD
University of Texas Southwestern Medical Center
Pharmacology    
Dallas, TX
david.corey@utsouthwestern.edu 
Mark A. Kay, MD, PhD
Dennis Farrey Family Professor
Departments of Pediatrics and Genetics
Vice Chair for Basic Research (Pediatrics)
Stanford University School of Medicine
Stanford, CA 
markay@stanford.edu
Brett P. Monia, PhD
Ionis Pharmaceuticals, Inc.
Antisense Drug Discovery
Carlsbad, CA
BMonia@ionisph.com
European Editor
Jens Kurreck, PhD
Technische Universität Berlin
Institute of Biotechnology, TIB 4/3-2
Department of Applied Biochemistry
Berlin, Germany
jens.kurreck@tu-berlin.de 
Asian Editor
Dong-ki Lee, PhD
Global Research Laboratory for RNAi Medicine
Department of Chemistry
Sungkyunkwan University
Suwon, Korea
dklee@skku.edu; dklee0318@gmail.com
Editorial Board
Sidney Altman
Yale University
New Haven, CT
Serge L. Beaucage
Food & Drug Administration
Bethesda, MD
Mark A. Behlke
Integrated DNA Technologies
Coralville, IA
Ben Berkhout
University of Amsterdam Medical Center
Amsterdam, Netherlands
Bob D. Brown
Dicerna Pharmaceuticals
Cambridge, MA
Natasha Caplen
National Cancer Institute
Bethesda, MD
Marvin H. Caruthers
University of Colorado
Boulder, CO
Masad J. Damha
McGill University
Montreal, Canada
Mark E. Davis
California Institute of Technology
Pasadena, CA
Steven F. Dowdy
University of California San Diego 
La Jolla, CA
Keith T. Gagnon, PhD
Southern Illinois University
Carbondale, IL
  
Michael Gait
Medical Research Council
Cambridge, United Kingdom
Krishna N. Ganesh
Indian Institute of Science Education and Research
Pune, India
Peter M. Glazer
Yale University
New Haven, CT
Martin Gleave
Vancouver General Hospital
Vancouver, Canada
Peixuan Guo
Ohio State University
Columbus, OH
Gunther Hartmann
Universitatsklinikum Bonn
Bonn, Germany
Richard I. Hogrefe
TriLink BioTechnologies, Inc
San Diego, CA
Leaf Huang
University of North Carolina 
Chapel Hill, NC

Said Ismail
University of Jordan 
Amman, Jordan
Dong-Yan Jin
University of Hong Kong
Pokfulam, Hong Kong
Anthony D. Keefe
X-Chem Pharmaceuticals
Waltham, MA
Soyoun Kim
Dongguk University
Seoul, Korea
Troels Koch
Santaris Pharma A/S
Hørsholm, Denmark
Ryszard Kole
University of North Carolina 
Chapel Hill, NC
Arthur M. Krieg
Checkmate Pharmaceuticals 
Boston, MA
Bernard Lebleu
Universite Montpellier
Montpellier, France
Seong-Wook Lee
Dankook University
Yongin, Korea
Ian MacLachlan
Tekmira Pharmaceuticals 
Burnaby, Canada  
Claude Malvy
Institut Gustave Roussy
Villejuif, France
Paul S. Miller
Johns Hopkins University
Baltimore, MD
Barbara Nawrot
Polish Academy of Sciences
Lodz, Poland

Frank Rigo 
Ionis Pharmaceuticals, Inc. 
Carlsbad, CA
Georg Sczakiel
University of Lübeck
Lübeck, Germany
Michael Seidman
National Institute on Aging
Baltimore, MD
Barbara Ramsay Shaw
Duke University
Durham, NC
Hermona Soreq
Hebrew University of Jerusalem 
Jerusalem, Israel
Wojciech Stec
Polish Academy of Sciences
Lodz, Poland
J.-J. Toulmé
Universite Victor Segalen 
Bordeaux, France
Thomas Tuschl
Rockefeller University
New York, NY
Takeshi Wada
University of Tokyo
Kashiwa, Japan

Jonathan Watts
RNA Therapeutics Institute, University of Massachusetts Medical School
Worcester, MA

Jesper Wengel
University of Southern Denmark
Odense, Denmark
Steve Wilton
University of Western Australia
Nedlands, Western Australia  
Yun Yen
Taipei Medical University 
Taipei, Taiwan